Physician profile
Chyna Moc
NPI 1538821780
$3,699.64
in general payments reported to CMS, 2019-2025
17 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $482 · 2023: $2,621 · 2024: $185 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $1,118 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $1,117.66 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $2,035.30 | 2023-2025 | Slynd, Nuvessa |
| Mayne Pharma Commercial LLC | $460.89 | 2022-2025 | |
| Astellas Pharma US INC | $234.03 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $189.24 | 2022-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Allergan, INC. | $162.50 | 2022 | |
| Myriad Women'S Health, INC. | $136.21 | 2023 | Myrisk |
| Abbvie INC. | $124.23 | 2022 | |
| Millicent US INC | $62.68 | 2025 | Intrarosa, Femring, Femlyv |
| Exact Sciences Corporation | $62.46 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Myovant Sciences INC. | $61.85 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.71 | 2024-2025 | |
| Biogen, INC. | $27.64 | 2025 | Zurzuvae |
| Organon LLC | $26.47 | 2024 | |
| Therapeuticsmd, INC. | $23.91 | 2022 | |
| Pfizer INC. | $20.47 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $18.20 | 2023 | Balcoltra |
| Kowa Pharmaceuticals America, INC. | $13.85 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chyna Moc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.